Anti-CD20 therapeutic compositions and methods

Details for Australian Patent Application No. 2008266952 (hide)

Owner Wyeth Trubion Pharmaceuticals, Inc.

Inventors Tchistiakova, Lioudmila; Damle, Nitin K.; Ledbetter, Jeffrey Alan; Simon, Sandy Alexander; Brady, William; Grosmaire, Laura Sue; Dunussi-Joannopoulos, Kyriaki

Agent Cullens

Pub. Number AU-A-2008266952

PCT Pub. Number WO2008/156713

Priority 60/934,341 12.06.07 US

Filing date 12 June 2008

Wipo publication date 24 December 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2008/156713 Priority application(s): WO2008/156713

11 March 2010 Alteration of Name

  The name of the applicant has been altered to Wyeth LLC; Trubion Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266954-CETP inhibitors derived from benzoxazole arylamides

2008266951-Antibodies to human programmed death receptor PD-1